Mechanism of action<unk>  targets the C1s enzyme and inhibits its enzymatic propagation of the classical complement pathway, thereby, preventing the formation of the C3-convertase enzyme.
Sutimlimab
Donanemab
Tafasitamab
Lepra 
Naxitamab
Sargramostim
Tebentafusp
Titermax